PepGen (PEPG) Interest & Investment Income (2022 - 2026)
PepGen (PEPG) reported Interest & Investment Income of $1.2 million for Q1 2026, up 11.41% on a YoY basis from $1.1 million in Q1 2025, and down 11.91% sequentially from $1.4 million in Q4 2025.
PepGen (PEPG) Interest & Investment Income (2022 - 2026) Analysis & Trends
PepGen (PEPG) has 5 years of Interest & Investment Income data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 11.41% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $4.1 million (down 36.51% YoY), and the FY2025 full-year result was $4.0 million, down 43.76% from the prior year.
- Interest & Investment Income fell to $1.2 million in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $2.1 million in Q2 2024 to a low of $9000.0 in Q1 2022.
- A 5-year average of $1.3 million and a median of $1.4 million in 2025 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income jumped 19811.11% in 2023 and plunged 65.28% in 2025, its largest moves.
- Tracing PEPG's Interest & Investment Income over 5 years: stood at $1.6 million in 2022, then dropped by 15.4% to $1.3 million in 2023, then climbed by 8.47% to $1.5 million in 2024, then dropped by 2.81% to $1.4 million in 2025, then declined by 11.91% to $1.2 million in 2026.
- Business Quant data shows PEPG's Interest & Investment Income at $1.2 million in Q1 2026, $1.4 million in Q4 2025, and $634000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | PepGen | 133.00 Mn | 133.00 Mn | - | 1.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 1.42 Mn |
| Sep 30, 2025 | 634,000.00 |
| Jun 30, 2025 | 842,000.00 |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 2.12 Mn |
| Mar 31, 2024 | 1.74 Mn |
| Dec 31, 2023 | 1.35 Mn |
| Sep 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 1.68 Mn |
| Mar 31, 2023 | 1.79 Mn |
| Dec 31, 2022 | 1.59 Mn |
| Sep 30, 2022 | 943,000.00 |
| Jun 30, 2022 | 250,000.00 |
| Mar 31, 2022 | 9,000.00 |